18 April 2024A reminder that a not-to-be-missed webinar takes place next week! Candesic Senior Partner Dr Michelle Tempest will be kicking off the Royal Society of…- 28 February 2024Candesic Managing Partner Dr Leonid Shapiro and Principal Dr Joe Taylor explore the intriguing applications of cerebral organoids in the latest edition of PharmaTimes. These artificially…
- 18 December 2023What does the EU framework for AI innovation and regulation mean for the future of healthcare in Europe? Dr Leonid…
- 11 December 2023Candesic Managing Partner Dr Leonid Shapiro and Principal Dr Joe Taylor discuss in an article in PharmaTimes Media Ltd how quantum computers can contribute to the development…
- 7 December 2023Candesic Senior Partner Dr Michelle Tempest joined Abdul Rahyead as a guest on a new episode of The Scrubbed In Show Podcast. The conversation centered on the transition…
- 6 December 2023Candesic Senior Partner and Cambridge Angels Investor Dr Michelle Tempest, featured in a report reviewing the UK's AI corporate ecosystem. The report was brought…
- 2 November 2023HealthInvestor features Dr Michelle Tempest, Senior Partner at Candesic, commenting on the government’s AI Life Sciences Accelerator Mission £100 million fund. The fund will…
- 1 November 2023Government initiatives such as the £100m investment programme to accelerate use of AI in life sciences, and the AI Safety…
11 October 2023andesic team, Dr Michelle Tempest and Juliet Frances Thornton in the new LaingBuisson HealthcareMarkets UK investigate the opportunities of electronic…- 5 June 2023At the Stifel AI conference organized by Stifel Financial Corp., the healthcare panel, moderated by David Vignon, CFA, had a…
